Blackrock Neurotech has the world’s largest portfolio of FDA-cleared Brain-Computer Interface (BCI) products. With their deep BCI experience, Blackrock serves as a collaborative development partner for medical device companies looking to bring novel neurological and neurosurgical products to market in different therapy areas, including epilepsy.